FDA official overseeing vaccines resigns amidst controversy

A key US Food and Drug Administration official responsible for vaccines is departing at the end of April. Vinay Prasad faced criticism for health policy decisions, particularly concerning Covid-19 vaccine efficacy. His exit follows controversies, including refusing to review a flu vaccine application. Prasad had previously raised doubts about Covid-19 vaccine safety.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/5WejPXN
via IFTTT

Read More

Key drug prices may surge on hoarding and higher demand

Escalating Middle East conflict is expected to increase demand for essential medicines. This surge could lead to higher drug prices, potentially benefiting Indian pharmaceutical manufacturers. Companies are monitoring the situation closely. Increased demand for chronic and acute therapy drugs is anticipated. Indian firms may see export disruptions but also higher overall demand if the conflict extends.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/S615dwf
via IFTTT

Read More

Obesity & diabetes are world's next health "tsunami", warns ebola discoverer Peter Piot

A leading virologist warns of a global tsunami of obesity and diabetes, surpassing viral threats. India faces significant vulnerability as diabetes rates surge. While pandemic preparedness has improved technically, societal trust remains a challenge. Innovations like new anti-obesity drugs offer hope but require broader access and lifestyle changes. India should prioritize discovery and innovation in biopharma.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/kTQ8t5R
via IFTTT

Read More

Pharma exports may take up to $500 million hit as freight costs rise

India's drug exports face a significant threat from the Iran war. Higher freight costs and shipping companies avoiding Gulf routes could impact shipments worth $300-500 million. This disruption affects both raw material imports from China and finished product exports to West Asia and beyond. Companies are building inventories to manage potential delays.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/ibVD5SK
via IFTTT

Read More

India & China must-win markets on rising middle-class households: Reckitt Chief

Reckitt Benckiser sees India and China as vital growth markets. The company's CEO highlighted the expanding middle class in these nations. Emerging markets are driving Reckitt's revenue expansion. India and China showed strong growth in the last quarter. This performance helped offset weaker results in developed markets. Reckitt aims to increase its reach in India through improved distribution.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/90FKEjL
via IFTTT

Read More

Iran war could disrupt India’s pharma exports by up to $500 million

The Iran war is impacting India's drug exports. Higher freight costs and shipping refusals to Gulf hubs are causing concern. Industry estimates suggest a potential loss of $300-$500 million. While manufacturing remains unaffected, logistics are complicated. Companies are maintaining inventories to ensure supply continuity. The situation could lead to temporary supply challenges.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/j9pxiSV
via IFTTT

Read More

India pharma exports risk disruption if Middle East conflict widens

Indian drug exports face significant challenges. A wider Middle East conflict could disrupt vital shipping routes. This may lead to longer transit times for temperature-sensitive medicines. Increased freight costs and potential delays in key markets like the UAE and Saudi Arabia are also concerns. Air cargo routes are also at risk.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/LhIpoxs
via IFTTT

Read More